Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Pacira BioSciences

< Previous 1 2 Next >
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Reports Third Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Announces Leadership Succession Plan
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Reports Second Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Reports First Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022
From Pacira BioSciences
Via GlobeNewswire
Tickers PCRX
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.